Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Functional Neuroimaging of the Enhanced Antidepressant Efficacy of Ketamine in a Biologically-Enriched Subgroup

NCT02122562 is registered in ClinicalTrials.gov with Mark Niciu as lead sponsor.

NCT NCT02122562
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02122562 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Functional Neuroimaging of the Enhanced Antidepressant Efficacy of Ketamine in a Biologically-Enriched Subgroup
Lead sponsor
Mark Niciu
Phase
Phase 2
Overall status
Recruiting
Start date
April 23, 2014
Completion date
September 30, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcoholism, magnetic resonance imaging, major depression